Seroprevalence of hepatitis B and C infection among Nigerian subjects with chronic kidney disease

Background and Objective: The prevalence of hepatitis virus infection in subjects with chronic kidney disease (CKD) has important implications for the etiology of kidney disease, infection safety in hemodialysis, and increases challenges in management consideration. The aim of this study was to det...

Full description

Bibliographic Details
Main Authors: Christiana Oluwatoyin Amira, Oluwafunmilayo Adenike Lesi
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2017-01-01
Series:Journal of Clinical Sciences
Subjects:
Online Access:http://www.jcsjournal.org/article.asp?issn=2468-6859;year=2017;volume=14;issue=2;spage=58;epage=61;aulast=Amira
_version_ 1811254147129802752
author Christiana Oluwatoyin Amira
Oluwafunmilayo Adenike Lesi
author_facet Christiana Oluwatoyin Amira
Oluwafunmilayo Adenike Lesi
author_sort Christiana Oluwatoyin Amira
collection DOAJ
description Background and Objective: The prevalence of hepatitis virus infection in subjects with chronic kidney disease (CKD) has important implications for the etiology of kidney disease, infection safety in hemodialysis, and increases challenges in management consideration. The aim of this study was to determine the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection among our patients with CKD before the commencement of dialysis. Methods: All CKD patients (n = 1388) dialyzed between January 1996 and December 2012 were enrolled into the study. Demographic data and etiology of CKD were extracted from case records. Patients were screened for HBV and HCV at initiation of dialysis. Hepatitis B surface antigen (HBsAg), HCV antibodies were measured using specific enzyme-linked immunoassay kits (Bio Rad Monalisa HBsAg ULTRA kit, Marnes–la-Coquette, France; HCV Dia.Pro Diagnostics Milano Italy, respectively). All subjects with HIV infection were excluded from the study. Results: The studied group comprised 511 (36.8%) females; the mean age of the patients was 46.1 ± 15.3 years. Eighty-three (6.0%) patients were HBsAg positive, whereas 16 (1.2%) were HCV antibody positive. No difference was observed in gender occurrence. Patients with chronic glomerulonephritis (GN) were significantly more likely to be HBsAg positive (9%) compared with those with hypertension (5.5%) or diabetes (5.3%) (P = 0.015). Conclusion: The prevalence of HBV in CKD patients was high, whereas HCV was low. HBV was significantly associated with chronic GN. Routine screening of all patients with CKD and before hemodialysis for HBV should be mandatory, especially in HBV endemic regions of the world.
first_indexed 2024-04-12T17:01:55Z
format Article
id doaj.art-ede6bcd8dc2d4eb3890dadcc23da9ec4
institution Directory Open Access Journal
issn 2468-6859
2408-7408
language English
last_indexed 2024-04-12T17:01:55Z
publishDate 2017-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Clinical Sciences
spelling doaj.art-ede6bcd8dc2d4eb3890dadcc23da9ec42022-12-22T03:24:03ZengWolters Kluwer Medknow PublicationsJournal of Clinical Sciences2468-68592408-74082017-01-01142586110.4103/2468-6859.204700Seroprevalence of hepatitis B and C infection among Nigerian subjects with chronic kidney diseaseChristiana Oluwatoyin AmiraOluwafunmilayo Adenike LesiBackground and Objective: The prevalence of hepatitis virus infection in subjects with chronic kidney disease (CKD) has important implications for the etiology of kidney disease, infection safety in hemodialysis, and increases challenges in management consideration. The aim of this study was to determine the prevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infection among our patients with CKD before the commencement of dialysis. Methods: All CKD patients (n = 1388) dialyzed between January 1996 and December 2012 were enrolled into the study. Demographic data and etiology of CKD were extracted from case records. Patients were screened for HBV and HCV at initiation of dialysis. Hepatitis B surface antigen (HBsAg), HCV antibodies were measured using specific enzyme-linked immunoassay kits (Bio Rad Monalisa HBsAg ULTRA kit, Marnes–la-Coquette, France; HCV Dia.Pro Diagnostics Milano Italy, respectively). All subjects with HIV infection were excluded from the study. Results: The studied group comprised 511 (36.8%) females; the mean age of the patients was 46.1 ± 15.3 years. Eighty-three (6.0%) patients were HBsAg positive, whereas 16 (1.2%) were HCV antibody positive. No difference was observed in gender occurrence. Patients with chronic glomerulonephritis (GN) were significantly more likely to be HBsAg positive (9%) compared with those with hypertension (5.5%) or diabetes (5.3%) (P = 0.015). Conclusion: The prevalence of HBV in CKD patients was high, whereas HCV was low. HBV was significantly associated with chronic GN. Routine screening of all patients with CKD and before hemodialysis for HBV should be mandatory, especially in HBV endemic regions of the world.http://www.jcsjournal.org/article.asp?issn=2468-6859;year=2017;volume=14;issue=2;spage=58;epage=61;aulast=AmiraChronic kidney diseasehemodialysishepatitis B virushepatitis C
spellingShingle Christiana Oluwatoyin Amira
Oluwafunmilayo Adenike Lesi
Seroprevalence of hepatitis B and C infection among Nigerian subjects with chronic kidney disease
Journal of Clinical Sciences
Chronic kidney disease
hemodialysis
hepatitis B virus
hepatitis C
title Seroprevalence of hepatitis B and C infection among Nigerian subjects with chronic kidney disease
title_full Seroprevalence of hepatitis B and C infection among Nigerian subjects with chronic kidney disease
title_fullStr Seroprevalence of hepatitis B and C infection among Nigerian subjects with chronic kidney disease
title_full_unstemmed Seroprevalence of hepatitis B and C infection among Nigerian subjects with chronic kidney disease
title_short Seroprevalence of hepatitis B and C infection among Nigerian subjects with chronic kidney disease
title_sort seroprevalence of hepatitis b and c infection among nigerian subjects with chronic kidney disease
topic Chronic kidney disease
hemodialysis
hepatitis B virus
hepatitis C
url http://www.jcsjournal.org/article.asp?issn=2468-6859;year=2017;volume=14;issue=2;spage=58;epage=61;aulast=Amira
work_keys_str_mv AT christianaoluwatoyinamira seroprevalenceofhepatitisbandcinfectionamongnigeriansubjectswithchronickidneydisease
AT oluwafunmilayoadenikelesi seroprevalenceofhepatitisbandcinfectionamongnigeriansubjectswithchronickidneydisease